Our findings suggest that such mechanism may compensate for HIF‐1α destabilization in CI‐deficient cancer model, laying the groundwork to future investigation on combinatorial strategies based on the synergistic inhibition of mitochondrial activity on one side and TME‐mediated adaptive response on the other [11]. This evidence concerns the gene HIF1A and cancer.